Bahijajallal
President, MedImmune and Executive Vice President,
Pharmaceutics
P3 communications?Inc
Lithuania
Biography
Skills and experience: Bahija was appointed Executive Vice-President, MedImmune in January 2013 and is responsible for biologics research and development activities. Bahija is tasked with advancing the biologics pipeline of medicines. She joined MedImmune in 2006 as Vice-President, Translational Sciences and has held roles of increasing responsibility at AstraZeneca. Prior to joining AstraZeneca, Bahija worked with Chiron Corporation, where she served as Vice-President, Drug Assessment and Development.
Research Interest
Pharmaceutics
